Tag: Patients
Top 3 EHR implementation risks and how to manage them
EHRs have finally gained widespread adoption. According to 2021 data, 96% of non-federal acute hospitals in the U.S. deployed an EHR system. Nevertheless, the EHR market faces numerous challenges. In fact, about a quarter…
Continue Reading
Top 3 electronic health record implementation risks and how to manage them
EHRs have finally gained widespread adoption. According to 2021 data, 96% of non-federal acute hospitals in the U.S. deployed an EHR system. Nevertheless, the EHR market faces numerous challenges. In fact, about a quarter…
Continue Reading
Top 3 electronic health records implementation risks and how to manage them
EHRs have finally gained widespread adoption. According to 2021 data, 96% of non-federal acute hospitals in the U.S. deployed an EHR system. Nevertheless, the EHR market faces numerous challenges. In fact, about a quarter…
Continue Reading
Ignoring RWD Endangers Drug Development
Life sciences organizations have access to more data than ever before. When they leverage that existing data during their research and development (R&D) process, organizations can drive more efficient drug development.
Innovation and regulatory approval…
Pediatric Mental Health Crisis Tops ECRI’s List of 2023 Patient Safety Concerns
The worsening mental health crisis among children and adolescents is the most pressing issue affecting patient safety, according to ECRI.
Each year, the nonprofit creates a list of the industry’s top ten patient safety concerns….
How Providers Across the US Are Caring For the Country’s 580,000+ Homeless People
In a fee-for-service world, it can be hard for health systems and other providers to prioritize caring for the homeless population, who carry some of the worst health risks of any other population in…
Continue Reading
ATA2023: Balancing Patient and Provider Experiences in the Continuum of Care
Panel participants discuss their experiences with remote monitoring strategies. From left to right: Moderators Greg Fulton, Industry and Public Policy Lead, Philips Population Health Management, and Bill Paschall, Senior Vice President of Growth and…
Continue Reading
Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B
What You Should Know:– Sanofi has agreed to acquire Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), for $25.00 per share in cash, representing an equity…
Continue Reading
Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients
Dr. Arti Masturzo, Chief Medical Officer at CCS Today, food insecurity affects more than 41 million Americans and is prevalent among children and the elderly population. Food insecurity is defined as the limited availability…
Continue Reading